OpenURL Connection Search

Select item for more details and to access through your institution.

Safety and clinical relief over 1 year with triamcinolone acetonide hydrofluoroalkane-134a nasal aerosol in patients with perennial allergic rhinitis.
Published in:
Allergy & Asthma Proceedings, 2006, v. 27, n. 3, p. 243, doi. 10.2500/aap.2006.27.2848
By:
- Weber, Richard;
- Garcia, Jorge;
- Faruqi, Rab;
- Banerji, Donald;
- Georges, George
Publication type:
Article
Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients.
Published in:
International Journal of COPD, 2020, v. 16, p. 1831, doi. 10.2147/COPD.S247966
By:
- Kostikas, Konstantinos;
- Mackay, Alexander J;
- Vogelmeier, Claus F;
- Frent, Stefan-Marian;
- Gupta, Pritam;
- Banerji, Donald;
- Patalano, Francesco;
- Pfister, Pascal J;
- Wedzicha, Jadwiga A
Publication type:
Article
Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.
Published in:
International Journal of COPD, 2018, v. 13, p. 1125, doi. 10.2147/COPD.S160011
By:
- Vogelmeier, Claus F;
- Chapman, Kenneth R;
- Miravitlles, Marc;
- Roche, Nicolas;
- Vestbo, Jørgen;
- Thach, Chau;
- Banerji, Donald;
- Fogel, Robert;
- Patalano, Francesco;
- Olsson, Petter;
- Kostikas, Konstantinos;
- Wedzicha, Jadwiga A
Publication type:
Article
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD.
Published in:
International Journal of COPD, 2017, v. 12, p. 1325, doi. 10.2147/COPD.S133307
By:
- Anzueto, Antonio R.;
- Vogelmeier, Claus F.;
- Kostikas, Konstantinos;
- Mezzi, Karen;
- Fucile, Sebastian;
- Bader, Giovanni;
- Shen, Steven;
- Banerji, Donald;
- Fogel, Robert
Publication type:
Article
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
Published in:
International Journal of COPD, 2017, v. 12, p. 339, doi. 10.2147/COPD.S125058
By:
- Wedzicha, Jadwiga A.;
- Nanshan Zhong;
- Masakazu Ichinose;
- Humphries, Michael;
- Fogel, Robert;
- Thach, Chau;
- Patalano, Francesco;
- Banerji, Donald
Publication type:
Article
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis.
Published in:
International Journal of COPD, 2016, v. 11, p. 3189, doi. 10.2147/COPD.S116786
By:
- Vogelmeier, Claus;
- Zhong, Nanshan;
- Humphries, Michael J.;
- Mezzi, Karen;
- Fogel, Robert;
- Bader, Giovanni;
- Patalano, Francesco;
- Banerji, Donald
Publication type:
Article
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study.
Published in:
International Journal of COPD, 2016, v. 11, p. 2543, doi. 10.2147/COPD.S111408
By:
- Shu Hashimoto;
- Hisataro Ikeuchi;
- Shujiro Murata;
- Tetsuji Kitawaki;
- Kimitoshi Ikeda;
- Banerji, Donald
Publication type:
Article
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Published in:
International Journal of COPD, 2015, p. 1015, doi. 10.2147/COPD.S84436
By:
- Nanshan Zhong;
- Changzheng Wang;
- Xiangdong Zhou;
- Nuofu Zhang;
- Humphries, Michael;
- Wang, Linda;
- Chau Thach;
- Patalano, Francesco;
- Banerji, Donald
Publication type:
Article
Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-tosevere COPD: psychometric results from the SHINE study.
Published in:
International Journal of COPD, 2015, p. 79, doi. 10.2147/COPD.S73092
By:
- Kulich, Károly;
- Keininger, Dorothy L.;
- Tiplady, Brian;
- Banerji, Donald
Publication type:
Article
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Published in:
International Journal of COPD, 2015, v. 10, p. 1015, doi. 10.2147/COPD.S84436
By:
- Nanshan Zhong;
- Changzheng Wang;
- Xiangdong Zhou;
- Nuofu Zhang;
- Humphries, Michael;
- Wang, Linda;
- Chau Thach;
- Patalano, Francesco;
- Banerji, Donald
Publication type:
Article
Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
Published in:
International Journal of COPD, 2015, v. 10, p. 79, doi. 10.2147/COPD.S73092
By:
- Kulich, Károly;
- Keininger, Dorothy L.;
- Tiplady, Brian;
- Banerji, Donald
Publication type:
Article
Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study.
Published in:
International Journal of COPD, 2013, v. 8, p. 501, doi. 10.2147/COPD.S49615
By:
- Dahl, Ronald;
- Jadayel, Dalal;
- Alagappan, Vijay K. T.;
- Hungta Chen;
- Banerji, Donald
Publication type:
Article
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD.
Published in:
International Journal of COPD, 2012, v. 7, p. 729, doi. 10.2147/COPD.S36001
By:
- Buhl, Roland;
- Banerji, Donald
Publication type:
Article
A novel model-based approach for dose determination of glycopyrronium bromide in COPD.
Published in:
BMC Pulmonary Medicine, 2012, v. 12, n. 1, p. 74, doi. 10.1186/1471-2466-12-74
By:
- Arievich, Helen;
- Overend, Tim;
- Renard, Didier;
- Gibbs, Michael;
- Alagappan, Vijay;
- Looby, Michael;
- Banerji, Donald
Publication type:
Article
Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.
Published in:
2019
By:
- Frent, Stefan M;
- Chapman, Kenneth R;
- Larbig, Michael;
- Mackay, Alexander;
- Fogel, Robert;
- Gutzwiller, Florian S;
- Shen, Steven;
- Patalano, Francesco;
- Banerji, Donald;
- Kostikas, Konstantinos;
- Wedzicha, Jadwiga A
Publication type:
journal article
Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations.
Published in:
2018
By:
- Mackay, Alex J;
- Kostikas, Konstantinos;
- Murray, Lindsey;
- Martinez, Fernando J;
- Miravitlles, Marc;
- Donaldson, Gavin;
- Banerji, Donald;
- Patalano, Francesco;
- Wedzicha, Jadwiga A
Publication type:
journal article
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Published in:
2018
By:
- Chapman, Kenneth R;
- Hurst, John R;
- Frent, Stefan-Marian;
- Larbig, Michael;
- Fogel, Robert;
- Guerin, Tadhg;
- Banerji, Donald;
- Patalano, Francesco;
- Goyal, Pankaj;
- Pfister, Pascal;
- Kostikas, Konstantinos;
- Wedzicha, Jadwiga A
Publication type:
journal article
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study.
Published in:
2018
By:
- Papi, Alberto;
- Kostikas, Konstantinos;
- Wedzicha, Jadwiga A.;
- Vogelmeier, Claus F.;
- Roche, Nicolas;
- Shen, Steven;
- Banerji, Donald;
- Fogel, Robert;
- Patalano, Francesco;
- Chapman, Kenneth R.
Publication type:
Letter
Reply to Cooper et al.: The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease.
Published in:
2018
By:
- Roche, Nicolas;
- Chapman, Kenneth R.;
- Vogelmeier, Claus F.;
- Herth, Felix J. F.;
- Chau Thach;
- Fogel, Robert;
- Olsson, Petter;
- Patalano, Francesco;
- Banerji, Donald;
- Wedzicha, Jadwiga A.;
- Thach, Chau
Publication type:
Letter
Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
Published in:
2017
By:
- Roche, Nicolas;
- Chapman, Kenneth R.;
- Vogelmeier, Claus F.;
- Herth, Felix J. F.;
- Chau Thach;
- Fogel, Robert;
- Olsson, Petter;
- Patalano, Francesco;
- Banerji, Donald;
- Wedzicha, Jadwiga A.;
- Thach, Chau
Publication type:
journal article
What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
Published in:
2017
By:
- Yilmaz, Insu;
- Turk, Murat;
- Roche, Nicolas;
- Chapman, Kenneth R.;
- Vogelmeier, Claus F.;
- Herth, Felix J. F.;
- Chau Thach;
- Fogel, Robert;
- Olsson, Petter;
- Patalano, Francesco;
- Banerji, Donald;
- Wedzicha, Jadwiga A.
Publication type:
journal article
Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.
Published in:
2017
By:
- Roche, Nicolas;
- Chapman, Kenneth R.;
- Vogelmeier, Claus F.;
- Herth, Felix J. F.;
- Chau Thach;
- Fogel, Robert;
- Olsson, Petter;
- Patalano, Francesco;
- Banerji, Donald;
- Wedzicha, Jadwiga A.;
- Thach, Chau
Publication type:
journal article
FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.
Published in:
2015
By:
- Mahler, Donald A.;
- Kerwin, Edward;
- Ayers, Tim;
- Taylor, Angel Fowler;
- Maitra, Samopriyo;
- Thach, Chau;
- Lloyd, Mark;
- Patalano, Francesco;
- Banerji, Donald;
- FowlerTaylor, Angel
Publication type:
journal article
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial.
Published in:
Respiratory Research, 2011, v. 12, n. 12, p. 1, doi. 10.1186/1465-9921-12-156
By:
- D'Urzo, Anthony;
- Ferguson, Gary T.;
- van Noord, Jan A.;
- Hirata, Kazuto;
- Martin, Carmen;
- Horton, Rachael;
- Yimeng Lu;
- Banerji, Donald;
- Overend, Tim
Publication type:
Article
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial.
Published in:
2011
By:
- D'Urzo, Anthony;
- Ferguson, Gary T;
- van Noord, Jan A;
- Hirata, Kazuto;
- Martin, Carmen;
- Horton, Rachael;
- Lu, Yimeng;
- Banerji, Donald;
- Overend, Tim
Publication type:
journal article
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Published in:
Lung, 2017, v. 195, n. 6, p. 739, doi. 10.1007/s00408-017-0055-9
By:
- Kerwin, Edward;
- Ferguson, Gary;
- Sanjar, Shahin;
- Goodin, Thomas;
- Yadao, Anthony;
- Fogel, Robert;
- Maitra, Samopriyo;
- Sen, Biswajit;
- Ayers, Tim;
- Banerji, Donald
Publication type:
Article
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
Published in:
2018
By:
- Anzueto, Antonio R.;
- Kostikas, Konstantinos;
- Mezzi, Karen;
- Shen, Steven;
- Larbig, Michael;
- Patalano, Francesco;
- Fogel, Robert;
- Banerji, Donald;
- Wedzicha, Jadwiga A.
Publication type:
journal article
NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.
Published in:
Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 3, p. 163, doi. 10.1177/1753465811406001
By:
- Vogelmeier, Claus;
- Banerji, Donald
Publication type:
Article
Risk-Benefit Value of Inhaled Glucocorticoids: a Pharmacokinetic/Pharmacodynamic Perspective.
Published in:
Journal of Clinical Pharmacology, 2004, v. 44, n. 1, p. 37
By:
- Shashank Rohatagi;
- Sireesh Appajosyula;
- Hartmut Derendorf;
- Stanley Szefler;
- Ruediger Nave;
- Karl Zech;
- Donald Banerji
Publication type:
Article
In Vitro and in Vivo Techniques Used in Drug Development for Evaluation of Dose Delivery of Inhaled Corticosteroids.
Published in:
Journal of Clinical Pharmacology, 2001, v. 41, n. 1, p. 7, doi. 10.1177/009127000104100i101
By:
- Rhodes, Gerald R.;
- Rohatagi, Shashank;
- Gillen, Michael S.;
- Deluccia, Frank;
- Banerji, Donald D.;
- Chaikin, Philip
Publication type:
Article
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study.
Published in:
2020
By:
- Mackay, Alexander J.;
- Kostikas, Konstantinos;
- Roche, Nicolas;
- Frent, Stefan-Marian;
- Olsson, Petter;
- Pfister, Pascal;
- Gupta, Pritam;
- Patalano, Francesco;
- Banerji, Donald;
- Wedzicha, Jadwiga A.
Publication type:
journal article

Found: 31